PERSPECTIVE THERAPEUTICS, INC. Amortization of Intangible Assets
PERSPECTIVE THERAPEUTICS, INC. (CATX) reported Amortization of Intangible Assets of $7.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-03-16
- PERSPECTIVE THERAPEUTICS, INC. amortization of intangible assets for fiscal 2025 was $7.00K, a 0.00% change from fiscal 2024.
- PERSPECTIVE THERAPEUTICS, INC. amortization of intangible assets for fiscal 2024 was $7.00K, a 0.00% change from fiscal 2023.
- PERSPECTIVE THERAPEUTICS, INC. amortization of intangible assets for fiscal 2023 was $7.00K.
- PERSPECTIVE THERAPEUTICS, INC. amortization of intangible assets for fiscal 2022 was $7.00K, a 81.08% decline from fiscal 2021.
| Period end | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 6 month as first filed | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|---|---|
| 2025-12-31 | $7.00K 10-K · filed 2026-03-16 | |||
| 2024-12-31 | $7.00K 10-K · filed 2026-03-16 | |||
| 2023-12-31 | $7.00K 10-K/A · filed 2025-03-28 | |||
| 2022-12-31 | $4.00K 10-K · filed 2024-03-28 | $21.00K 10-KT · filed 2023-05-01 | ||
| 2022-06-30 | $7.00K 10-K · filed 2024-03-28 | $41.00K 10-K · filed 2022-09-28 | ||
| 2021-06-30 | $37.00K 10-KT · filed 2023-05-01 | |||
| 2020-06-30 | $38.00K 10-KT · filed 2023-05-01 | |||
| 2019-06-30 | $50.00K 10-K · filed 2021-09-27 | |||
| 2018-06-30 | $50.00K 10-K · filed 2020-09-25 | |||
| 2017-06-30 | $45.00K 10-K · filed 2019-09-27 | |||
| 2016-06-30 | $107.00K 10-K · filed 2018-09-26 | $80.94K 10-K · filed 2016-09-09 | ||
| 2015-06-30 | $37.00K 10-K · filed 2017-09-28 | $25.23K 10-K · filed 2015-09-14 | ||
| 2014-06-30 | $18.47K 10-K · filed 2016-09-09 | |||
| 2013-06-30 | $19.58K 10-K · filed 2015-09-14 | |||
| 2012-06-30 | $15.73K 10-K · filed 2013-09-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |